Autologous Peripheral-Blood Mononuclear Cells Including A Minimum Of 50 Million Autologous Cd54+ Cells Activated With Prostatic Acid Phosphatase Granulocyte-Macrophage Colony-Stimulating Factor
An immunotherapy product made from a patient's own immune cells that are activated outside the body against a prostate cancer antigen and then infused back to stimulate an immune response against prostate cancer cells. It is the first FDA-approved cancer vaccine for castration-resistant prostate cancer.
Mecanismo de acción
Stimulates the adaptive immune system to produce antigen-specific antibodies and memory cells, providing protective immunity against subsequent exposure to the pathogen.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Stimulates the adaptive immune system to produce antigen-specific antibodies and memory cells, providing protective immunity against subsequent exposure to the pathogen.
HBD / HBA
- / -
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Preguntas frecuentes
An immunotherapy product made from a patient's own immune cells that are activated outside the body against a prostate cancer antigen and then infused back to stimulate an immune response against prostate cancer cells. It is the first FDA-approved cancer vaccine for castration-resistant prostate cancer.
Stimulates the adaptive immune system to produce antigen-specific antibodies and memory cells, providing protective immunity against subsequent exposure to the pathogen.
Yes, Autologous Peripheral-Blood Mononuclear Cells Including A Minimum Of 50 Million Autologous Cd54+ Cells Activated With Prostatic Acid Phosphatase Granulocyte-Macrophage Colony-Stimulating Factor is an approved drug. It has reached clinical phase 4. It is classified as a Unknown.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL5315067. Open-access bioactivity database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="autologous-peripheral-blood-mononuclear-cells-including-a-minimum-of-50-million-autologous-cd54-cells-activated-with-prostatic-acid-phosphatase-granulocyte-macrophage-colony-stimulating-factor"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/autologous-peripheral-blood-mononuclear-cells-including-a-minimum-of-50-million-autologous-cd54-cells-activated-with-prostatic-acid-phosphatase-granulocyte-macrophage-colony-stimulating-factor/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/autologous-peripheral-blood-mononuclear-cells-including-a-minimum-of-50-million-autologous-cd54-cells-activated-with-prostatic-acid-phosphatase-granulocyte-macrophage-colony-stimulating-factor/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/autologous-peripheral-blood-mononuclear-cells-including-a-minimum-of-50-million-autologous-cd54-cells-activated-with-prostatic-acid-phosphatase-granulocyte-macrophage-colony-stimulating-factor/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="autologous-peripheral-blood-mononuclear-cells-including-a-minimum-of-50-million-autologous-cd54-cells-activated-with-prostatic-acid-phosphatase-granulocyte-macrophage-colony-stimulating-factor"></drugfyi-drug>